首页> 美国卫生研究院文献>other >Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells
【2h】

Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells

机译:非专业抗原呈递和树突状细胞中MHC I类分子的内吞再循环

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Major histocompatibility complex class I (MHC I) molecules are glycoproteins that display peptide epitopes at the cell surface of nucleated cells for recognition by CD8+ T cells. Like other cell surface receptors, MHC class I molecules are continuously removed from the surface followed by intracellular degradation or recycling to the cell surface, in a process likely involving active quality control the mechanism of which remains unknown. The molecular players and pathways involved in internalization and recycling have previously been studied in model cell lines such as HeLa. However, dendritic cells (DCs), which rely on a specialized endocytic machinery that confers them the unique ability to “cross”-present antigens acquired by internalization, may use distinct MHC I recycling pathways and quality control mechanisms. By providing MHC I molecules cross-presenting antigens, these pathways may play an important role in one of the key functions of DCs, priming of T cell responses against pathogens and tumors. In this review, we will focus on endocytic recycling of MHC I molecules in various experimental conditions and cell types. We discuss the organization of the recycling pathway in model cell lines compared to DCs, highlighting the differences in the recycling rates and pathways of MHC I molecules between various cell types, and their putative functional consequences. Reviewing the literature, we find that conclusive evidence for significant recycling of MHC I molecules in primary DCs has yet to be demonstrated. We conclude that endocytic trafficking of MHC class I in DCs remains poorly understood and should be further studied because of its likely role in antigen cross-presentation.
机译:主要的组织相容性复合物I类(MHC I)分子是糖蛋白,在有核细胞的细胞表面显示肽表位,可被CD8 + T细胞识别。像其他细胞表面受体一样,MHC I类分子会从表面连续去除,然后细胞内降解或循环到细胞表面,这一过程可能涉及主动质量控制,其机制尚不清楚。先前已在模型细胞系(例如HeLa)中研究了涉及内在化和循环利用的分子和途径。但是,依赖于专门的内吞机制的树突状细胞(DC)赋予它们独特的“交叉”内在化获得的抗原的能力,可以使用独特的MHC I回收途径和质量控制机制。通过提供交叉呈递抗原的MHC I分子,这些途径可能在DC的关键功能之一(引发针对病原体和肿瘤的T细胞反应)中发挥重要作用。在这篇综述中,我们将重点研究在各种实验条件和细胞类型下MHC I分子的内吞再循环。我们讨论了与DC相比模型细胞系中回收途径的组织,重点介绍了各种细胞类型之间MHC I分子回收率和途径的差异,以及它们可能的功能后果。回顾文献,我们发现主要DC中MHC I分子大量回收的确凿证据尚未得到证实。我们得出的结论是,DC中内吞MHC I类的运输仍知之甚少,由于其可能在抗原交叉呈递中发挥作用,因此应进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号